Intravascular contrast agents in diagnostic applications: Use of red blood cells to improve the lifespan and efficacy of blood pool contrast agents
暂无分享,去创建一个
[1] Jung-Woo Choi,et al. Intravenous Imaging Contrast Media Complications: The Basics That Every Clinician Needs to Know. , 2015, The American journal of medicine.
[2] M. Taupitz,et al. Cardiac magnetic resonance angiography using blood-pool contrast agents: comparison of citrate-coated very small superparamagnetic iron oxide particles with gadofosveset trisodium in pigs. , 2012, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
[3] Bixiang Zhang,et al. Solitary Perihepatic Splenosis Mimicking Liver Lesion , 2015, Medicine.
[4] S. Saini,et al. MR contrast material for vascular enhancement: value of superparamagnetic iron oxide. , 1996, AJR. American journal of roentgenology.
[5] D. Saloner,et al. USPIO-enhanced MR angiography of arteriovenous fistulas in patients with renal failure. , 2012, Radiology.
[6] S. Aime,et al. Biodistribution of gadolinium‐based contrast agents, including gadolinium deposition , 2009, Journal of magnetic resonance imaging : JMRI.
[7] K. Murase,et al. Encapsulation of Iron Oxide Nanoparticles into Red Blood Cells as a Potential Contrast Agent for Magnetic Particle Imaging , 2014 .
[8] P. Grenier,et al. CT diagnosis of ureteral fibroepithelial polyps , 2002, European Radiology.
[9] Sang Joon Lee,et al. Gold nanoparticle-incorporated human red blood cells (RBCs) for X-ray dynamic imaging. , 2011, Biomaterials.
[10] S. Gambhir,et al. Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.
[11] Kai Liu,et al. Rapid size-controlled synthesis of dextran-coated, 64Cu-doped iron oxide nanoparticles. , 2012, ACS nano.
[12] S. Bhatt,et al. Contrast Induced Nephropathy with Intravenous Iodinated Contrast Media in Routine Diagnostic Imaging: An Initial Experience in a Tertiary Care Hospital , 2016, Radiology research and practice.
[13] A. Akbarzadeh,et al. An update on clinical applications of magnetic nanoparticles for increasing the resolution of magnetic resonance imaging , 2016, Artificial cells, nanomedicine, and biotechnology.
[14] M. Bernardo-Filho,et al. Drug interaction with radiopharmaceuticals: effect on the labeling of red blood cells with technetium-99m and on the bioavailability of radiopharmaceuticals , 2002 .
[15] M. Magnani,et al. Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides , 2002, Gene Therapy.
[16] John E. Johnson,et al. Fluorescent signal amplification of carbocyanine dyes using engineered viral nanoparticles. , 2006, Journal of the American Chemical Society.
[17] P. Reimer,et al. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications , 2003, European Radiology.
[18] Matthias Graeser,et al. Magnetic particle imaging: current developments and future directions , 2015, International journal of nanomedicine.
[19] C. Quattrocchi,et al. Gadolinium-based contrast agents: did we miss something in the last 25 years? , 2016, La radiologia medica.
[20] J. Witjes,et al. Ferumoxtran-10 ultrasmall superparamagnetic iron oxide-enhanced diffusion-weighted imaging magnetic resonance imaging for detection of metastases in normal-sized lymph nodes in patients with bladder and prostate cancer: do we enter the era after extended pelvic lymph node dissection? , 2013, European urology.
[21] J. M. Lanao,et al. Drug-loaded erythrocytes: on the road toward marketing approval , 2016, Drug design, development and therapy.
[22] Hans Bäumler,et al. Surface-modified loaded human red blood cells for targeting and delivery of drugs , 2012, Journal of microencapsulation.
[23] C. Alexiou,et al. Cardiovascular therapy through nanotechnology – how far are we still from bedside? , 2014 .
[24] D. Hippe,et al. A Comparison between Gadofosveset Trisodium and Gadobenate Dimeglumine for Steady State MRA of the Thoracic Vasculature , 2014, BioMed research international.
[25] Ralph Weissleder,et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.
[26] B. Zubelewicz-Szkodzińska,et al. Radiocontrast‐induced thyroid dysfunction: is it common and what should we do about it? , 2014, Clinical endocrinology.
[27] Junjie Yao,et al. Conditional HIF-1 induction produces multistage neovascularization with stage-specific sensitivity to VEGFR inhibitors and myeloid cell independence. , 2011, Blood.
[28] C. Goergen,et al. Molecular Imaging of Experimental Abdominal Aortic Aneurysms , 2013, TheScientificWorldJournal.
[29] Wei Li,et al. First‐pass contrast‐enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)‐based blood pool agent , 2005, Journal of magnetic resonance imaging : JMRI.
[30] Lihong V. Wang,et al. Photoacoustic tomography: principles and advances. , 2016, Electromagnetic waves.
[31] Frank J Rybicki,et al. CT angiography: current technology and clinical use. , 2010, Radiologic clinics of North America.
[32] A. Neville,et al. Retrospective assessment of the utility of an iron‐based agent for contrast‐enhanced magnetic resonance venography in patients with endstage renal diseases , 2014, Journal of magnetic resonance imaging : JMRI.
[33] Samir Mitragotri,et al. Multifunctional nanoparticles for drug delivery and molecular imaging. , 2013, Annual review of biomedical engineering.
[34] S. Aime,et al. Frequency-encoded MRI-CEST agents based on paramagnetic liposomes/RBC aggregates. , 2014, Nano letters.
[35] René M. Botnar,et al. Cardiovascular magnetic resonance imaging in small animals. , 2012, Progress in molecular biology and translational science.
[36] Lihong V. Wang,et al. Functional photoacoustic microscopy for high-resolution and noninvasive in vivo imaging , 2006, Nature Biotechnology.
[37] Yongmin Chang,et al. Gold nanoparticles functionalized by gadolinium-DTPA conjugate of cysteine as a multimodal bioimaging agent. , 2010, Bioorganic & medicinal chemistry letters.
[38] R. Hoffman. Recent advances on in vivo imaging with fluorescent proteins. , 2008, Methods in cell biology.
[39] Antonella Antonelli,et al. Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents. , 2011, Nanomedicine.
[40] J. Nuyts,et al. Preclinical evaluation of carbon-11 and fluorine-18 sulfonamide derivatives for in vivo radiolabeling of erythrocytes , 2013, EJNMMI Research.
[41] S. Jain,et al. Magnetically responsive diclofenac sodium-loaded erythrocytes: preparation and in vitro characterization. , 1994, Journal of microencapsulation.
[42] E. Terreno,et al. Lanthanide-loaded erythrocytes as highly sensitive chemical exchange saturation transfer MRI contrast agents. , 2014, Journal of the American Chemical Society.
[43] J. Bulte,et al. New “multicolor” polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI , 2008, Magnetic resonance in medicine.
[44] Y. Li,et al. High-Pitch, Low-Voltage and Low-Iodine-Concentration CT Angiography of Aorta: Assessment of Image Quality and Radiation Dose with Iterative Reconstruction , 2015, PloS one.
[45] Borut Marincek,et al. Optimal image reconstruction intervals for non-invasive coronary angiography with 64-slice CT , 2006, European Radiology.
[46] J. Franconi,et al. Positive contrast high-resolution 3D-cine imaging of the cardiovascular system in small animals using a UTE sequence and iron nanoparticles at 4.7, 7 and 9.4 T , 2015, Journal of Cardiovascular Magnetic Resonance.
[47] Paula M Jacobs,et al. Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? , 2009, Kidney international.
[48] A. Malhotra,et al. Comparative Evaluation of Tc-99m-Heat-Denatured RBC and Tc-99m-Anti-D IgG Opsonized RBC Spleen Planar and SPECT Scintigraphy in the Detection of Accessory Spleen in Postsplenectomy Patients With Chronic Idiopathic Thrombocytopenic Purpura , 2004, Clinical nuclear medicine.
[49] David R Vera,et al. A molecular CT blood pool contrast agent. , 2002, Academic radiology.
[50] T. Goto,et al. Utility of contrast‐enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma , 2011, Journal of gastroenterology and hepatology.
[51] Katie L Stabi,et al. Ferumoxytol Use as an Intravenous Contrast Agent for Magnetic Resonance Angiography , 2011, The Annals of pharmacotherapy.
[52] Eliana Gianolio,et al. Insights into the use of paramagnetic Gd(III) complexes in MR‐molecular imaging investigations , 2002, Journal of magnetic resonance imaging : JMRI.
[53] Tim Leiner,et al. MR Angiography of Collateral Arteries in a Hind Limb Ischemia Model: Comparison between Blood Pool Agent Gadomer and Small Contrast Agent Gd-DTPA , 2011, PloS one.
[54] H. Atkins,et al. Splenic sequestration of 99mTc labeled, heat treated red blood cells. , 1980, Radiology.
[55] Paula M Jacobs,et al. Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast Agent , 2006, Investigative radiology.
[56] M. Magnani,et al. New biomimetic constructs for improved in vivo circulation of superparamagnetic nanoparticles. , 2008, Journal of nanoscience and nanotechnology.
[57] R. Lawaczeck,et al. Superparamagnetic iron oxide particles: contrast media for magnetic resonance imaging , 2004 .
[58] Xu Xiao. Photoacoustic imaging in biomedicine , 2008 .
[59] S. Emelianov,et al. Photoacoustic Imaging for Cancer Detection and Staging. , 2013, Current molecular imaging.
[60] Ralph Weissleder,et al. Long-circulating iron oxides for MR imaging , 1995 .
[61] Martin R Prince,et al. 3D contrast‐enhanced MR angiography , 2007, Journal of magnetic resonance imaging : JMRI.
[62] B Gleich,et al. Human erythrocytes as nanoparticle carriers for magnetic particle imaging , 2010, Physics in medicine and biology.
[63] M. Magnani,et al. Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studies. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[64] B Gleich,et al. Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection , 2013, Physics in medicine and biology.
[65] J. Witjes,et al. Prostate Cancer : Detection of Lymph Node Metastases Outside the Routine Surgical Area with Ferumoxtran-10 – enhanced MR Imaging 1 , 2009 .
[66] U. Sprandel,et al. Magnetically responsive erythrocyte ghosts. , 1987, Methods in enzymology.
[67] Angelo Bifone,et al. Neuroimaging Evidence of Altered Fronto-Cortical and Striatal Function after Prolonged Cocaine Self-Administration in the Rat , 2011, Neuropsychopharmacology.
[68] M. Laguerre,et al. In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes. , 1990, Alcohol and alcoholism.
[69] T. Balcı,et al. Incidental DTPA and DMSA uptake during renal scanning in unknown bone metastases , 2006, Annals of nuclear medicine.
[70] J. Ewing,et al. Sickle red blood cells accumulate in tumor , 2003, Magnetic resonance in medicine.
[71] J. A. Spicer,et al. The effects of selected antineoplastic agents on the labeling of erythrocytes with technetium-99m using the UltraTag RBC kit. , 1999, Journal of nuclear medicine technology.
[72] M. Prince,et al. Gadolinium-enhanced magnetic resonance angiography of abdominal aortic aneurysms. , 1995, Journal of vascular surgery.
[73] Martin Requardt,et al. Contrast‐enhanced MR angiography of the run‐off vasculature: Intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine , 2003, Journal of magnetic resonance imaging : JMRI.
[74] Éva Tóth,et al. The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging , 2013 .
[75] E. Terreno,et al. Osmotically shrunken LIPOCEST agents: an innovative class of magnetic resonance imaging contrast media based on chemical exchange saturation transfer. , 2009, Chemistry.
[76] Shigeyuki Aoki,et al. Contrast‐enhanced ultrasound using a time‐intensity curve for the diagnosis of renal cell carcinoma , 2011, BJU international.
[77] M. Imaizumi,et al. Cerebral hemodynamics and metabolism in adult moyamoya disease: Comparison of angiographic collateral circulation , 2004, Annals of nuclear medicine.
[78] William J Powers,et al. Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited. , 2002, Brain : a journal of neurology.
[79] Allen W. Song,et al. Duke review of MRI principles , 2012 .
[80] Kevin M. Johnson,et al. Gadolinium‐bearing red cells as blood pool MRI contrast agents , 1998, Magnetic resonance in medicine.
[81] RES‐specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR‐angiography , 1999, Journal of magnetic resonance imaging : JMRI.
[82] Sophie Laurent,et al. Classification and basic properties of contrast agents for magnetic resonance imaging. , 2009, Contrast media & molecular imaging.
[83] Hua Ai,et al. Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications. , 2014, Current opinion in pharmacology.
[84] A. Plebani,et al. Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia , 2015, Neurology: Neuroimmunology & Neuroinflammation.
[85] R. Hunt,et al. A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects. , 2000, The American journal of medicine.
[86] B. Hamm,et al. Coronary MR angiography using citrate‐coated very small superparamagnetic iron oxide particles as blood‐pool contrast agent: Initial experience in humans , 2011, Journal of magnetic resonance imaging : JMRI.
[87] D. Patton. A Clinician's Guide to Nuclear Medicine , 2001 .
[88] W. Verboom,et al. Targeted lipoCEST contrast agents for magnetic resonance imaging: alignment of aspherical liposomes on a capillary surface. , 2010, Angewandte Chemie.
[89] Samuel Achilefu,et al. Monitoring the biodegradation of dendritic near-infrared nanoprobes by in vivo fluorescence imaging. , 2008, Molecular pharmaceutics.
[90] M. O’Donnell,et al. Multifunctional nanoparticles as coupled contrast agents. , 2010, Nature communications.
[91] Samuel Achilefu,et al. Near-infrared dichromic fluorescent carbocyanine molecules. , 2008, Angewandte Chemie.
[92] S. Srivastava,et al. Radionuclide-labeled red blood cells: current status and future prospects. , 1984, Seminars in nuclear medicine.
[93] K. Kearfott. Absorbed dose estimates for positron emission tomography (PET): C15O, 11CO, and CO15O. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[94] D. Pareto,et al. Erythrocytes labeled with [(18) F]SFB as an alternative to radioactive CO for quantification of blood volume with PET. , 2013, Contrast media & molecular imaging.
[95] Michael C. Kolios,et al. On the use of photoacoustics to detect red blood cell aggregation , 2012, Biomedical optics express.
[96] A de Roos,et al. Blood pool contrast agents for cardiovascular MR imaging , 1999, Journal of magnetic resonance imaging : JMRI.
[97] M. Port,et al. Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents , 2007, International journal of nanomedicine.
[98] David K. Menon,et al. Intrinsic Activated Microglia Map to the Peri-infarct Zone in the Subacute Phase of Ischemic Stroke , 2006, Stroke.
[99] A. Tanimoto,et al. Enhancement of phase‐contrast MR angiography with superparamagnetic iron oxide , 1998, Journal of magnetic resonance imaging : JMRI.
[100] J. Sandstede,et al. Deep venous thrombosis and consecutive pulmonary embolism as the first sign of an ovarian cancer: MR angiography using an intravascular contrast agent (CLARISCAN) , 2000, Journal of magnetic resonance imaging : JMRI.
[101] Francis Vocanson,et al. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. , 2008, Journal of the American Chemical Society.
[102] Jason M Warram,et al. The status of contemporary image-guided modalities in oncologic surgery. , 2015, Annals of surgery.
[103] N. Zöllner,et al. Osmotic fragility of drug carrier erythrocytes , 1985, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.
[104] Antonella Antonelli,et al. Magnetic red blood cells as new contrast agents for MRI applications , 2013, Medical Imaging.
[105] Lihong V. Wang,et al. Label-free photoacoustic ophthalmic angiography. , 2010, Optics letters.
[106] E. Terreno,et al. Lanthanide-loaded paramagnetic liposomes as switchable magnetically oriented nanovesicles. , 2008, Inorganic chemistry.
[107] Seong-Jang Kim,et al. Depressive mood in pre-dialytic chronic kidney disease: Statistical parametric mapping analysis of Tc-99m ECD brain SPECT , 2009, Psychiatry Research: Neuroimaging.
[108] A. Iadanza,et al. MR angiography of the carotid arteries and intracranial circulation: advantage of a high relaxivity contrast agent , 2006, Neuroradiology.
[109] E. Gianolio,et al. An MRI Method To Map Tumor Hypoxia Using Red Blood Cells Loaded with a pO2-Responsive Gd-Agent. , 2015, ACS nano.
[110] T. Belzunegui,et al. Extravasation of radiographic contrast material and compartment syndrome in the hand: a case report , 2011, Scandinavian journal of trauma, resuscitation and emergency medicine.
[111] J. Steinbach,et al. Synthesis and biological evaluation of a novel 99mTc cyclopentadienyl tricarbonyl complex ([(Cp-R)99mTc(CO)3]) for sigma-2 receptor tumor imaging. , 2012, Bioorganic & medicinal chemistry letters.
[112] Simon J. Graham,et al. Magnetic Resonance Imaging to Visualize Stroke and Characterize Stroke Recovery: A Review , 2013, Front. Neurol..
[113] E. Rubinstein,et al. Fluorescence Dilution Technique for Measurement of Cardiac Output and Circulating Blood Volume in Healthy Human Subjects , 2007, Anesthesiology.
[114] Carolyn L Bayer,et al. PHOTOACOUSTIC IMAGING FOR MEDICAL DIAGNOSTICS. , 2012, Acoustics today.
[115] I. Pesaresi,et al. MR Angiography Contrast Agents , 2010 .
[116] Sanjiv S Gambhir,et al. Self-illuminating quantum dot conjugates for in vivo imaging , 2006, Nature Biotechnology.
[117] Geoffrey C Gurtner,et al. Intraoperative laser angiography using the SPY system: review of the literature and recommendations for use , 2013, Annals of surgical innovation and research.
[118] Bahman Anvari,et al. In-vivo fluorescence imaging of mammalian organs using charge-assembled mesocapsule constructs containing indocyanine green. , 2008, Optics express.
[119] Xuanjun Zhang,et al. Au Nanocage Functionalized with Ultra-small Fe3O4 Nanoparticles for Targeting T1–T2Dual MRI and CT Imaging of Tumor , 2016, Scientific Reports.
[120] J. Gillard,et al. Iron oxide particles for atheroma imaging. , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[121] E. Fleck,et al. The intravascular contrast agent Clariscan™ (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease , 2000, Magma: Magnetic Resonance Materials in Physics, Biology, and Medicine.
[122] A. Elster. Incidence of Immediate Gadolinium Contrast Media Reactions , 2012 .
[123] Ernst Klotz,et al. New techniques in CT angiography. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.
[124] Thorsten M. Buzug. Computed Tomography: From Photon Statistics to Modern Cone-Beam CT , 2010 .
[125] Bernhard Gleich,et al. Fundamentals and applications of magnetic particle imaging. , 2012, Journal of cardiovascular computed tomography.
[126] Parag Aggarwal,et al. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. , 2009, Advanced drug delivery reviews.
[127] J. Mintorovitch,et al. Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths , 2005, Investigative radiology.
[128] W. K. Bolton,et al. Pharmacokinetic Study of Ferumoxytol: A New Iron Replacement Therapy in Normal Subjects and Hemodialysis Patients , 2005, American Journal of Nephrology.
[129] F. Kiessling,et al. Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects. , 2015, Chemical reviews.
[130] Dimitris Mihailidis,et al. Computed Tomography: From Photon Statistics to Modern Cone-Beam CT , 2008 .
[131] John A Hossack,et al. In vivo imaging of microfluidic-produced microbubbles , 2015, Biomedical microdevices.
[132] M Geso,et al. Gold nanoparticles: a new X-ray contrast agent. , 2007, The British journal of radiology.
[133] M. Petretta,et al. Beyond ultrasound: advances in multimodality cardiac imaging , 2015, Internal and Emergency Medicine.
[134] J. Wildberger,et al. Feasibility of low contrast media volume in CT angiography of the aorta , 2015, European journal of radiology open.
[135] P. Scarborough,et al. Cardiovascular disease in Europe 2014: epidemiological update. , 2014, European heart journal.
[136] Martin Rohrer,et al. Clinical blood pool MR imaging , 2008 .
[137] Samuel Achilefu,et al. Bright fluorescent nanoparticles for developing potential optical imaging contrast agents. , 2010, Nanoscale.
[138] Yi-Xiang J. Wang. Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application. , 2011, Quantitative imaging in medicine and surgery.
[139] Antonella Antonelli,et al. Red blood cells as carriers of iron oxide-based contrast agents for diagnostic applications. , 2014, Journal of biomedical nanotechnology.
[140] Raquel Delgado-Mederos,et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. , 2006, Stroke.
[141] A. Plebani,et al. Intra-Erythrocyte Infusion of Dexamethasone Reduces Neurological Symptoms in Ataxia Teleangiectasia Patients: Results of a Phase 2 Trial , 2014, Orphanet Journal of Rare Diseases.
[142] Stanislav Y. Emelianov,et al. Biomedical Applications of Photoacoustic Imaging with Exogenous Contrast Agents , 2011, Annals of Biomedical Engineering.
[143] Chuanqing Zhou,et al. Mesoporous silica-coated gold nanorods with embedded indocyanine green for dual mode X-ray CT and NIR fluorescence imaging. , 2011, Optics express.
[144] Deirdre B. Cassidy,et al. Revisiting the risks of MRI with Gadolinium based contrast agents—review of literature and guidelines , 2015, Insights into Imaging.
[145] William J Powers,et al. Regional cerebrovascular and metabolic effects of hyperventilation after severe traumatic brain injury. , 2002, Journal of neurosurgery.
[146] Griselda J. Garrido,et al. A voxel-based investigation of regional cerebral blood flow abnormalities in obsessive–compulsive disorder using single photon emission computed tomography (SPECT) , 2000, Psychiatry Research: Neuroimaging.
[147] Liangzhong Xiang,et al. Characterization of the temperature rise in a single cell during photoacoustic tomography at the nanoscale , 2016, Journal of biomedical optics.
[148] Kannan M. Krishnan,et al. In vivo Delivery, Pharmacokinetics, Biodistribution and Toxicity of Iron Oxide Nanoparticles , 2016 .
[149] C. Marx,et al. SPIO‐enhanced 2D‐TOF MR angiography of the portal venous system: Results of an intraindividual comparison , 1997, Journal of magnetic resonance imaging : JMRI.
[150] Sarah E Bohndiek,et al. Contrast agents for molecular photoacoustic imaging , 2016, Nature Methods.
[151] M Oudkerk,et al. Safety and Efficacy of Dotarem (Gd-DOTA) versus Magnevist (Gd-DTPA) in Magnetic Resonance Imaging of the Central Nervous System , 1995, Investigative radiology.
[152] W. Heindel,et al. First‐pass and equilibrium‐MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study , 2004, NMR in biomedicine.
[153] Tilcock. Delivery of contrast agents for magnetic resonance imaging, computed tomography, nuclear medicine and ultrasound. , 1999, Advanced drug delivery reviews.
[154] T. Hirai,et al. Reduction of contrast material volume in 3D angiography of the brain using MDCT. , 2010, AJR. American journal of roentgenology.
[155] A. Orekhov,et al. Local prevention of thrombosis in animal arteries by means of magnetic targeting of aspirin-loaded red cells. , 1990, Thrombosis research.
[156] C. Ho,et al. New look at hemoglobin allostery. , 2015, Chemical reviews.
[157] G. Germano,et al. EANM/ESC guidelines for radionuclide imaging of cardiac function , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[158] M. Magnani,et al. USPIO-loaded red blood cells as a biomimetic MR contrast agent: a relaxometric study. , 2014, Contrast media & molecular imaging.
[159] C. Higgins,et al. Blood pool MR contrast agents for cardiovascular imaging , 2000, Journal of magnetic resonance imaging : JMRI.
[160] Zahi A Fayad,et al. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography , 2007, Nature Medicine.
[161] M. Magnani,et al. Erythrocyte-based drug delivery , 2005, Expert opinion on drug delivery.
[162] Justin J. Konkle,et al. Magnetic Particle Imaging With Tailored Iron Oxide Nanoparticle Tracers , 2015, IEEE Transactions on Medical Imaging.
[163] Anke M Hövels,et al. Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging. , 2009, Radiology.
[164] C. Chambon,et al. Gd-DOTA loaded into red blood cells, a new magnetic resonance imaging contrast agents for vascular system. , 1992, Advances in experimental medicine and biology.
[165] M. Port,et al. How to Compare the Efficiency of Albumin-Bound and Nonalbumin-Bound Contrast Agents In Vivo: The Concept of Dynamic Relaxivity , 2005, Investigative radiology.
[166] Bahman Anvari,et al. Optical nano-constructs composed of genome-depleted brome mosaic virus doped with a near infrared chromophore for potential biomedical applications. , 2011, ACS nano.
[167] Jørgen Arendt Jensen,et al. Medical ultrasound imaging. , 2007, Progress in biophysics and molecular biology.
[168] Fabian Kiessling,et al. Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery , 2015, Front. Pharmacol..
[169] Junjie Yao,et al. Sensitivity of photoacoustic microscopy , 2014, Photoacoustics.
[170] Daniele Marin,et al. Emerging applications for ferumoxytol as a contrast agent in MRI , 2015, Journal of magnetic resonance imaging : JMRI.
[171] R. Flower,et al. Observation of erythrocyte dynamics in the retinal capillaries and choriocapillaris using ICG-loaded erythrocyte ghost cells. , 2008, Investigative ophthalmology & visual science.
[172] Peter Caravan,et al. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. , 2006, Chemical Society reviews.
[173] Nitish V. Thakor,et al. Conjugated polymer nanoparticles for photoacoustic vascular imaging , 2014 .
[174] S. Aime,et al. Gd-loaded-RBCs for the assessment of tumor vascular volume by contrast-enhanced-MRI. , 2015, Biomaterials.
[175] Isabelle Raynal,et al. Superparamagnetic Contrast Agents , 2007 .
[176] R. Willette,et al. Differential uptake of ferumoxtran‐10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: Critical determinants of atherosclerotic plaque labeling , 2005, Journal of magnetic resonance imaging : JMRI.
[177] K. Kang,et al. Near infrared dye indocyanine green doped silica nanoparticles for biological imaging. , 2012, Talanta.
[178] T. Sen,et al. Design of water-based ferrofluids as contrast agents for magnetic resonance imaging. , 2011, Journal of colloid and interface science.
[179] Lihong V. Wang,et al. Noninvasive laser-induced photoacoustic tomography for structural and functional in vivo imaging of the brain , 2003, Nature Biotechnology.
[180] Sheng-Wen Huang,et al. Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging. , 2007, Journal of biomedical optics.
[181] J. Hossack,et al. Microbubble-mediated intravascular ultrasound imaging and drug delivery , 2015, IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control.
[182] Junjie Yao,et al. VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting , 2011, Proceedings of the National Academy of Sciences.
[183] M. Moseley,et al. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. , 1990, Radiology.
[184] P. Speelman,et al. Assessment of splenic function , 2010, European Journal of Clinical Microbiology & Infectious Diseases.
[185] B. Bax,et al. Survival of human carrier erythrocytes in vivo. , 1999, Clinical science.
[186] Martin R Prince,et al. Blood pool MR angiography of aortic stent-graft endoleak. , 2004, AJR. American journal of roentgenology.
[187] Lin Zhao,et al. Parallel Comparative Studies on Mouse Toxicity of Oxide Nanoparticle- and Gadolinium-Based T1 MRI Contrast Agents. , 2015, ACS nano.
[188] Acoustically active red blood cell carriers for ultrasound-triggered drug delivery with photoacoustic tracking , 2015, 2015 IEEE International Ultrasonics Symposium (IUS).
[189] Konstantin Nikolaou,et al. 25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives , 2016, Advances in Therapy.
[190] U Teichgräber,et al. Magnetite-loaded carrier erythrocytes as contrast agents for magnetic resonance imaging. , 2006, Nano letters.
[191] A. S. Moses,et al. Imaging and drug delivery using theranostic nanoparticles. , 2010, Advanced drug delivery reviews.
[192] Bahman Anvari,et al. Effects of nanoencapsulation and PEGylation on biodistribution of indocyanine green in healthy mice: quantitative fluorescence imaging and analysis of organs , 2013, International journal of nanomedicine.
[193] Soren D. Konecky,et al. Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI. , 2005, Medical physics.
[194] Yuki Shinohara,et al. Interindividual Variations of Cerebral Blood Flow, Oxygen Delivery, and Metabolism in Relation to Hemoglobin Concentration Measured by Positron Emission Tomography in Humans , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[195] Michael P. Chae,et al. Indocyanine green-based fluorescent angiography in breast reconstruction. , 2016, Gland surgery.
[196] S. Maderwald,et al. Contrast-Enhanced Magnetic Resonance Angiography in Rabbits: Evaluation of the Gadolinium-Based Agent P846 and the Iron-Based Blood Pool Agent P904 in Comparison With Gadoterate Meglumine , 2011, Investigative radiology.
[197] B Gleich,et al. Three-dimensional real-time in vivo magnetic particle imaging , 2009, Physics in medicine and biology.
[198] SatoshiKuroda,et al. Cerebral Oxygen Metabolism and Neuronal Integrity in Patients With Impaired Vasoreactivity Attributable to Occlusive Carotid Artery Disease , 2006 .
[199] S. Libutti,et al. Using positron emission tomography 2-deoxy-2-[18F]fluoro-D-glucose, 11CO, and 15O-water for monitoring androgen independent prostate cancer. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[200] B. Hamm,et al. Phase I Clinical Evaluation of Citrate-coated Monocrystalline Very Small Superparamagnetic Iron Oxide Particles as a New Contrast Medium for Magnetic Resonance Imaging , 2004, Investigative radiology.
[201] M. Goyen,et al. Gadofosveset-enhanced magnetic resonance angiography , 2008, Vascular health and risk management.
[202] Samuel A Wickline,et al. Manganese-based MRI contrast agents: past, present and future. , 2011, Tetrahedron.
[203] P. Ascenzi,et al. Metal complexes as allosteric effectors of human hemoglobin: an NMR study of the interaction of the gadolinium(III) bis(m-boroxyphenylamide)diethylenetriaminepentaacetic acid complex with human oxygenated and deoxygenated hemoglobin. , 1999, Biophysical journal.
[204] Merlijn Hutteman,et al. The clinical use of indocyanine green as a near‐infrared fluorescent contrast agent for image‐guided oncologic surgery , 2011, Journal of surgical oncology.
[205] Baohua Zhang,et al. Gd(III) functionalized gold nanorods for multimodal imaging applications. , 2011, Nanoscale.
[206] P. Decuzzi,et al. Paramagnetic Gd(3+) labeled red blood cells for magnetic resonance angiography. , 2016, Biomaterials.
[207] S. Vasanawala,et al. Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children , 2015, Pediatric Radiology.
[208] Alexander A Oraevsky,et al. Red blood cell as a universal optoacoustic sensor for non-invasive temperature monitoring. , 2014, Applied physics letters.
[209] Geng Ku,et al. Noninvasive imaging of hemoglobin concentration and oxygenation in the rat brain using high-resolution photoacoustic tomography. , 2006, Journal of biomedical optics.
[210] Bahman Anvari,et al. Erythrocyte-derived photo-theranostic agents: hybrid nano-vesicles containing indocyanine green for near infrared imaging and therapeutic applications , 2013, Scientific Reports.
[211] B. Hamm,et al. First-Pass Whole-Body Magnetic Resonance Angiography (MRA) Using the Blood-Pool Contrast Medium Gadofosveset Trisodium: Comparison to Gadopentetate Dimeglumine , 2007, Investigative radiology.
[212] H. Lusic,et al. X-ray-computed tomography contrast agents. , 2013, Chemical reviews.
[213] Enzo Terreno,et al. Highly sensitive MRI chemical exchange saturation transfer agents using liposomes. , 2005, Angewandte Chemie.
[214] A. Wiethoff,et al. Initial imaging recommendations for Vasovist angiography , 2006, European radiology.
[215] Bernhard Gleich,et al. Tomographic imaging using the nonlinear response of magnetic particles , 2005, Nature.
[216] Efstathios P. Efstathopoulos,et al. Iron Oxide Nanoparticles as Contrast Agents in Molecular Magnetic Resonance Imaging: Do They Open New Perspectives in Cardiovascular Imaging? , 2015, Cardiology in review.
[217] Mark D Pagel,et al. A review of responsive MRI contrast agents: 2005-2014. , 2015, Contrast media & molecular imaging.
[218] A. Annapragada. Advances in nanoparticle imaging technology for vascular pathologies. , 2015, Annual review of medicine.
[219] A E Stillman,et al. Use of an intravascular T1 contrast agent to improve MR cine myocardial‐blood pool definition in man , 1997, Journal of magnetic resonance imaging : JMRI.
[220] Jürgen K Willmann,et al. Acoustic and Photoacoustic Molecular Imaging of Cancer , 2013, The Journal of Nuclear Medicine.
[221] S. Xirasagar,et al. Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease , 2012, Clinical kidney journal.
[222] M. Magnani,et al. Characterization of ferucarbotran-loaded RBCs as long circulating magnetic contrast agents. , 2016, Nanomedicine.
[223] Jean Coudane,et al. Aliphatic polyesters for medical imaging and theranostic applications. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[224] J. Glowniak,et al. Comparison of in vitro RBC labeling with the UltraTag RBC kit versus in vivo labeling. , 1991, Journal of Nuclear Medicine.
[225] M. Magnani,et al. New Strategies to Prolong the In Vivo Life Span of Iron-Based Contrast Agents for MRI , 2013, PloS one.
[226] Sumit Arora,et al. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers , 2012, International journal of nanomedicine.
[227] S. Laurent,et al. Comprehensive investigation of the non-covalent binding of MRI contrast agents with human serum albumin , 2007, JBIC Journal of Biological Inorganic Chemistry.
[228] C. Bremer,et al. Myocardial perfusion and MR angiography of chest with SH U 555 C: results of placebo-controlled clinical phase i study. , 2004, Radiology.
[229] H. Thomsen,et al. Contrast medium extravasation injury: guidelines for prevention and management , 2002, European Radiology.
[230] Andreas Raabe,et al. Prospective evaluation of surgical microscope-integrated intraoperative near-infrared indocyanine green videoangiography during aneurysm surgery. , 2005, Journal of neurosurgery.
[231] Thorsten M. Buzug,et al. Comprar Computed Tomography · From Photon Statistics to Modern Cone-Beam CT | Buzug, Thorsten M. | 9783540394075 | Springer , 2008 .
[232] Zhuang Liu,et al. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. , 2008, Nature nanotechnology.
[233] E. Moralidis,et al. A single measurement with 51Cr-tagged red cells or 125I-labeled human serum albumin in the prediction of fractional and whole blood volumes: an assessment of the limitations , 2009, Physiological measurement.
[234] Zijian Zhou,et al. Surface and interfacial engineering of iron oxide nanoplates for highly efficient magnetic resonance angiography. , 2015, ACS nano.
[235] Oguz K. Baskurt,et al. Handbook of hemorheology and hemodynamics , 2007 .
[236] Annet Waaijer,et al. Circle of Willis at CT angiography: dose reduction and image quality--reducing tube voltage and increasing tube current settings. , 2007, Radiology.
[237] D. Thomas,et al. Studies on regional cerebral haematocrit and blood flow in patients with cerebral tumours using positron emission tomography. , 1986, Microvascular research.
[238] Manuela Semmler-Behnke,et al. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. , 2010, Biomaterials.
[239] Richard Solomon,et al. Side Effects of Radiographic Contrast Media: Pathogenesis, Risk Factors, and Prevention , 2014, BioMed research international.
[240] D. Bilecen,et al. MR angiography with blood pool contrast agents , 2007, European Radiology.
[241] K. Chuang,et al. Magnetic resonance imaging (MRI) contrast agents for tumor diagnosis. , 2013, Journal of healthcare engineering.
[242] P. Couvreur. Nanoparticles in drug delivery: past, present and future. , 2013, Advanced drug delivery reviews.
[243] D. Parker. Rare Earth Coordination Chemistry in Action: Exploring the Optical and Magnetic Properties of the Lanthanides in Bioscience While Challenging Current Theories , 2016 .
[244] J. Lewin,et al. A new type of susceptibility-artefact-based magnetic resonance angiography: intra-arterial injection of superparamagnetic iron oxide particles (SPIO) A Resovist in combination with TrueFisp imaging: a feasibility study. , 2006, Contrast media & molecular imaging.
[245] Y. Kato,et al. Intra operative indocyanine green video-angiography in cerebrovascular surgery: An overview with review of literature , 2011, Asian journal of neurosurgery.
[246] D. Rubello,et al. Preoperative Diagnosis of Orbital Cavernous Hemangioma: A 99mTc-RBC SPECT Study , 2012, Clinical nuclear medicine.
[247] E. Terreno,et al. LipoCEST and cellCEST imaging agents: opportunities and challenges. , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[248] L. M. Wong Kee Song,et al. Technetium-labeled erythrocyte scintigraphy in acute gastrointestinal bleeding , 2013, International Journal of Colorectal Disease.
[249] Catherine C. Berry,et al. Functionalisation of magnetic nanoparticles for applications in biomedicine : Biomedical applications of magnetic nanoparticles , 2003 .
[250] Erin Grady. Gastrointestinal Bleeding Scintigraphy in the Early 21st Century , 2016, The Journal of Nuclear Medicine.
[251] S. Jain,et al. Preparation and in vitro characterization of a magnetically responsive ibuprofen-loaded erythrocytes carrier. , 1994, Journal of microencapsulation.
[252] Sangjin Park,et al. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. , 2007 .